A. Rosa Borges

Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1.

F. Krebs, D. Birx, F. McCutchan, 2010, Virology.

Identification and Characterization of a Broadly Cross-Reactive HIV-1 Human Monoclonal Antibody That Binds to Both gp120 and gp41

D. Dimitrov, Yuxing Li, Richard Wilson, 2012, PloS one.

Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models.

E. Sanders-Buell, M. Robb, D. Birx, 2008, Virology.

Dendrimers and antivirals: a review.

C. Schengrund, A. Rosa Borges, 2005, Current drug targets. Infectious disorders.

Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.

David C Montefiori, Susan Zolla-Pazner, Nelson L Michael, 2008, Virology.

Mitigation of variation observed in a peripheral blood mononuclear cell (PBMC) based HIV-1 neutralization assay by donor cell pooling.

D. Montefiori, N. Michael, B. Brown, 2013, Virology.

Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.

S. Zolla-Pazner, D. Dimitrov, D. Montefiori, 2008, Virology.